FDA Determines Regulatory Review Period for CORE VALVE SYSTEM Patent Extension

Summary

The US Food and Drug Administration (FDA) has officially confirmed the regulatory review period for the CORE VALVE SYSTEM medical device patent extension, as required by law, following a submission to the US Patent and Trademark Office (USPTO)